ARCHIVES

Phase III Trial Fails to Extend OS After Meeting Primary Endpoint Of Durable Response Rate

This article is from The Cancer Letter archive.

Vol. 37 No. 4 | April 25, 2014

Download PDF Visit The Full Archive

Related Articles

Clinical Cooperative Groups Funding To Decrease 42.5 Mil.

October 11, 1985

DCT Board Approves Recompetition Of Clinical Trials, Other Contracts, New BNCT Grants

October 28, 1988

SAIC Awarded $5 Billion Contract For NCI-Frederick.

October 3, 2008

L.A. County Nears Crucial Decision On Construction Funds

January 7, 1977

Finasteride Cut Risk Of Prostate Cancer In Large Trial, But Value In Clinic Unclear.

June 27, 2003

Vanderbilt Lung Cancer Trial For Never Smokers Online

September 25, 2009